Stanford researchers at the Okamura Lab have prototyped a computerized "pillow" that fits in the hand and uses air pressure to measure involuntary grip force (spastic hypertonia).
Researchers at Stanford have developed a microparticle-based vaccine that in a single shot enables enhanced activation of CD8+ and/or CD4+ T cells to fight against infectious diseases and cancer.
Stanford researchers are investigating a new method and possible apparatus for neurostimulation of the cochlea for restoration of hearing while minimizing damage to residual hearing.
Stanford researchers have used deep learning to create a radiotherapy treatment plan verification algorithm. Patient specific dose verification is traditionally done by checking the dose in a patient-mimicking phantom or by using an independent dose calculation algorithm.
Researchers at Stanford and the Chan Zuckerberg Biohub have discovered cross reactive, broadly neutralizing human antibodies against all serotypes of dengue virus.
Engineered cytotoxic T cells are a promising class of cell therapies. These living drugs are capable of selectively killing blood cancers, such as acute myeloid leukemia (AML), and delaying its progression.
Ear infections are a serious condition, especially in children, and represent a $4B market. Otitis media (OM) is when the middle ear becomes inflamed and affects 90% of children worldwide.
Researchers at Stanford have developed synthetic derivatives of a natural product, azapodophyllotoxin (AZP), that exhibit remarkable anticancer activities.
Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have generated a crystal structure for human PD-1 in complex with one of its ligands, PD-L2, for use in small molecule inhibitor design.
This methodology computes the marginal energy utilization for supplying individual water users based on the existing topology of the water distribution network (WDN), pipe sizes and baseline flows.